FDA's Elizabeth Dickinson Is Named Acting Chief Counsel
This article was originally published in The Pink Sheet Daily
Executive Summary
Dickinson, who has been a staff attorney since 1994, takes the helm from Ralph Tyler on an interim basis.
You may also be interested in...
FDA Looks Inside For Chief Counsel, Taps Elizabeth Dickinson
Former FDA attorneys laud her appointment, saying she is highly regarded inside and outside the agency for her intelligence, warmth and expertise on Hatch-Waxman and other key issues.
As FDA Reorganizes, Office Of Chief Counsel Becomes Less Political
Along with the creation of "directorate" level offices at the commissioner level, FDA also is making a significant change to the chief counsel position following the departure of Ralph Tyler on Aug. 5.
As FDA Reorganizes, Office Of Chief Counsel Becomes Less Political
Along with the creation of "directorate" level offices at the commissioner level, FDA also is making a significant change to the chief counsel position following the departure of Ralph Tyler on Aug. 5.